Predictive marker of responsiveness of anemia in non-dialytic CKD to long acting erythropoiesis stimulating agent
Not Applicable
- Conditions
- non-dialytic chronic kidney disease
- Registration Number
- JPRN-UMIN000006494
- Lead Sponsor
- Department of Kidney Disease and Hypertension Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1 Severe hypertension 2 Congestive heart failure (NYHE III or IV) 3 Myocardial infarction, pulmonary infarction of cerebral infarction within 6 months 4 Active infection 5 Malignant tumor and hematological disease 6 erythropoietin use within 6 months 7 Transfusion within 6 months 8 Patients whom doctor judged inappropriate as participant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in hemoglobin after 8 weeks from starting ESA
- Secondary Outcome Measures
Name Time Method Increase in hemoglobin above the level at which ESA is recommended to stop in the guideline